Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative Medicine
Cells · 2023
DOI: 10.3390/cells12101442 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Derek A Ogi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Thomas J. Watson College of Engineering and Applied Sciences, State University of New York at Binghamton, Bingh…. Hauptthemen laut MEDLINE: Pluripotent Stem Cells, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, the National Institutes of Health, the National Science Foundation.
Abstract (Originalsprache)
Pluripotent stem cells are endless sources for in vitro engineering human tissues for regenerative medicine. Extensive studies have demonstrated that transcription factors are the key to stem cell lineage commitment and differentiation efficacy. As the transcription factor profile varies depending on the cell type, global transcriptome analysis through RNA sequencing (RNAseq) has been a powerful tool for measuring and characterizing the success of stem cell differentiation. RNAseq has been utilized to comprehend how gene expression changes as cells differentiate and provide a guide to inducing cellular differentiation based on promoting the expression of specific genes. It has also been utilized to determine the specific cell type. This review highlights RNAseq techniques, tools for RNAseq data interpretation, RNAseq data analytic methods and their utilities, and transcriptomics-enabled human stem cell differentiation. In addition, the review outlines the potential benefits of the transcriptomics-aided discovery of intrinsic factors influencing stem cell lineage commitment, transcriptomics applied to disease physiology studies using patients’ induced pluripotent stem cell (iPSC)-derived cells for regenerative medicine, and the future outlook on the technology and its implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Thomas J. Watson College of Engineering and Applied Sciences, State University of New York at Binghamton, Binghamton, NY 13902, USA.
- Center of Biomanufacturing for Regenerative Medicine, State University of New York at Binghamton, Binghamton, NY 13902, USA.
ORCID-Profile: Sha Jin
Förderung
- NIH HHS
- the National Institutes of Health
- the National Science Foundation
Zitieren
APA
Ogi, D. A., & Jin, S. (2023). Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative Medicine. Cells. https://doi.org/10.3390/cells12101442
Vancouver
Ogi DA, Jin S. Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative Medicine. Cells. 2023. doi:10.3390/cells12101442
BibTeX
@article{Ogi2023,
author = {Ogi, Derek A and Jin, Sha},
title = {Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative Medicine},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12101442}
}
EUVIMED